Company intelligence / Profile preview
AncoCare Pharmatech
Beijing, Beijing, Chinaancocare.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
AncoCare Pharmatech is a clinical-stage biotechnology company based in Beijing, China, specializing in the development of innovative cancer immunotherapies. The company leverages a proprietary mRNA technology platform to design and manufacture personalized neoantigen-based vaccines and other nucleic acid therapeutics. Their lead pipeline programs focus on treating advanced solid tumors by utilizing mRNA-LNP delivery systems to stimulate robust T-cell responses against patient-specific mutations. AncoCare aims to bridge the gap between bioinformatics-driven drug design and advanced manufacturing to deliver highly individualized medicine.
- Therapeutic areas
- Oncology
- Modalities
- mRNA-based drugsLipid nanoparticle delivery therapyVaccineImmunotherapy
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on AncoCare Pharmatech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AncoCare Pharmatech.